Skip to main navigation Skip to search Skip to main content

Early versus delayed erythropoietin for the anaemia of end-stage kidney disease

  • Jorge Coronado Daza
  • , Amaury Ariza García
  • , Joaquín Rodelo Ceballos
  • , Nancy Yomayusa González
  • , Gerard Urrútia
  • , César Loza Munárriz
  • , Carol Páez-Canro
  • University of Cartagena
  • Universidad de Antioquia
  • Universidad Sanitas
  • Centro de Investigación Biomédica en Red de Epidemiología y Salud Publica
  • Universidad Nacional de Colombia, Facultad de Medicina

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the clinical benefits and harms of early versus delayed EPO for anaemia in patients with ESKD undergoing haemodialysis or peritoneal dialysis.

Original languageEnglish
Article numberCD011122
JournalCochrane Database of Systematic Reviews
Volume2014
Issue number5
DOIs
StatePublished - 20 May 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this